The Journal of Pediatrics
Volume 150, Issue 4 , Pages 351-357 , April 2007

Neonatal Hydrocortisone Treatment: Neurodevelopmental Outcome and MRI at School Age in Preterm-born Children

Received 10 March 2006 ,Revised 19 August 2006 ,Accepted 11 October 2006.

References 

  1. Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, et al. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996: NICHD Neonatal Research Network. Pediatrics. 2001;107:E1
  2. Halliday HL, Ehrenkranz RA, Doyle LW. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2003;CD001146
  3. Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics. 1998;101:E7
  4. O’Shea TM, Kothadia JM, Klinepeter KL, Goldstein DJ, Jackson BG, Weaver RG, et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics. 1999;104:15–21
  5. Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed. 2000;83:F177–F181
  6. Baud O. Postnatal steroid treatment and brain development. Arch Dis Child Fetal Neonatal Ed. 2004;89:F96–F100
  7. Lodygensky GA, Rademaker K, Zimine S, Gex-Fabry M, Lieftink AF, Lazeyras F, et al. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease. Pediatrics. 2005;116:1–7
  8. Rademaker KJ, Rijpert M, Uiterwaal CS, Lieftink AF, van Bel F, Grobbee DE, et al. Neonatal hydrocortisone treatment related to 1H-MRS of the hippocampus and short-term memory at school age in preterm born children. Pediatr Res. 2006;59:309–313
  9. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 gm. J Pediatr. 1978;92:529–534
  10. de Vries LS, Eken P, Dubowitz LM. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res. 1992;49:1–6
  11. Rademaker KJ, Lam JN, van Haastert IC, Uiterwaal CS, Lieftink AF, Groenendaal F, et al. Larger corpus callosum size with better motor performance in prematurely born children. Semin Perinatol. 2004;28:279–287
  12. Kaufman AS. Intelligent Testing With the WISC-R. 1979. New York, NY: Wiley; 1979;
  13. Rey A. L’examen clinique en psychologie. Paris: Presses Universitaires de France; 2005;
  14. Beery KE. The VMI Developmental Test of Visual Motor Integration: Administration, Scoring and Teaching Manual. Cleveland, Ohio: Modern Curriculum Press; 1997;
  15. Hendersen SE, Sugden ED. The Movement Assessment Battery for Children. London, UK: The Psychological Cooperation Ltd; 1992;
  16. Kurth T, Walker AM, Glynn RJ, Chan KA, Gaziano JM, Berger K, et al. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol. 2006;163:262–270
  17. Baden M, Bauer CR, Colle E, Klein G, Taeusch HW, Stern L. A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome. Pediatrics. 1972;50:526–534
  18. Taeusch HW, Wang NS, Baden N, Bauer CR, Stern L. A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome, II: Pathology. Pediatrics. 1973;52:850–854
  19. Fitzhardinge PM, Eisen A, Lejtenyi C, Metrakos K, Ramsay M. Sequelae of early steroid administration to the newborn infant. Pediatrics. 1974;53:877–883
  20. Mammel MC, Green TP, Johnson DE, Thompson TR. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet. 1983;1:1356–1358
  21. Avery GB, Fletcher AB, Kaplan M, Brudno DS. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics. 1985;75:106–111
  22. Hack M, Fanaroff AA. Outcomes of children of extremely low birthweight and gestational age in the 1990s. Early Hum Dev. 1999;53:193–218
  23. Thebaud B, Lacaze-Masmonteil T, Watterberg K. Postnatal glucocorticoids in very preterm infants: ’the good, the bad, and the ugly’?. Pediatrics. 2001;107:413–415
  24. Andre P, Thebaud B, Odievre MH, Razafimahefa H, Zupan V, Dehan M, et al. Methylprednisolone, an alternative to dexamethasone in very premature infants at risk of chronic lung disease. Intensive Care Med. 2000;26:1496–1500
  25. Decastro MH, LaGamma EF. Postnatal use of betamethasone (BETA) vs dexamethasone (DEX) for treatment of evolving BPD in extremely low birth weight (ELBW) neonates (abstract). Pediatr Res. 2005;2069A
  26. Heide-Jalving M, Kamphuis PJ, van der Laan MJ, Bakker JM, Wiegant VM, Heijnen CJ, et al. Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone?. Acta Paediatr. 2003;92:827–835
  27. Watterberg KL, Gerdes JS, Gifford KL, Lin HM. Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics. 1999;104:1258–1263
  28. Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC, et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics. 2004;114:1649–1657
  29. Watterberg KL, Scott SM, Backstrom C, Gifford KL, Cook KL. Links between early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus. Pediatrics. 2000;105:320–324
  30. Reist M, Marshall KA, Jenner P, Halliwell B. Toxic effects of sulphite in combination with peroxynitrite on neuronal cells. J Neurochem. 1998;71:2431–2438
  31. Baud O, Laudenbach V, Evrard P, Gressens P. Neurotoxic effects of fluorinated glucocorticoid preparations on the developing mouse brain: role of preservatives. Pediatr Res. 2001;50:706–711
  32. Finer NN, Powers RJ, Ou CH, Durand D, Wirtschafter D, Gould JB. Prospective evaluation of postnatal steroid administration: a 1-year experience from the California Perinatal Quality Care Collaborative. Pediatrics. 2006;117:704–713
  33. Halliday HL, Ehrenkranz RA, Doyle LW. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2003;CD001144
  34. Halliday HL, Ehrenkranz RA, Doyle LW. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2003;CD001145
  35. Grier DG, Halliday HL. Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use. Drugs. 2005;65:15–29

 This study was supported by University Medical Center Utrecht (Zonproject).

PII: S0022-3476(06)01016-X

doi: 10.1016/j.jpeds.2006.10.051

The Journal of Pediatrics
Volume 150, Issue 4 , Pages 351-357 , April 2007

Article Tools